Abbott, Alere Antitrust Mediation Ends Without ResolutionBy
Alere suit claims Abbott is deliberately delaying FTC approval
Case reverts to Delaware judge who suggested failed mediation
Efforts to have a mediator resolve antitrust disagreements in Abbott Laboratories’ stalled $5.8 billion takeover of Alere Inc. have failed, Alere said in a regulatory filing Monday.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.